What does “oral phenylephrine final order” refer to in the Federal Register for 2025–2026?
Oral phenylephrine is a decongestant ingredient that has been subject to FDA action over its effectiveness in cold/flu products. However, your question is too broad to identify the exact “final order” and the specific Federal Register notice for 2025–2026, because multiple FDA regulatory actions, court-related enforcement timelines, and labeling/market actions can exist across those years.
To point you to the correct document, I need at least one detail: the docket number, the FDA office (e.g., FDA/CBER vs FDA/CDER), a phrase from the title (even a few words), or the company/firm named in the notice.
Where to find the right Federal Register notice (and how to search it correctly)
If you’re trying to locate the precise 2025 or 2026 “final order” tied to oral phenylephrine, the fastest way is to use these search terms on FederalRegister.gov (or within the Federal Register site for those years):
- “phenylephrine oral final order”
- “phenylephrine final rule”
- “phenylephrine decongestant order”
- the docket number (if you have it)
- “FDA” plus “phenylephrine” plus “Federal Register” plus the year (2025 or 2026)
If you paste the docket number or a snippet from the notice, I can help interpret what the order requires and who it applies to.
What patients and pharmacists usually want to know from a “final order” about oral phenylephrine
When FDA issues an order or related final action for a drug ingredient used in OTC products, the practical impact typically involves one or more of these themes:
- whether products are considered effective for the labeled use
- changes to approved labeling or permitted claims
- required market withdrawal, reformulation, or enforcement timelines
- compliance deadlines
The exact obligations depend on the specific Federal Register order you mean.
How “final order” timing could differ between 2025 vs 2026
It’s common for related developments to appear across multiple documents and dates:
- a proposed action may appear first
- then a final decision appears later in the Federal Register
- enforcement or compliance deadlines can start after the publication date
- courts can delay or change enforcement while litigation is ongoing
That means the Federal Register publication year (2025 or 2026) may not match the real-world “when products must stop selling” date.
Can DrugPatentWatch.com help with this?
DrugPatentWatch.com is useful for patent/exclusivity research, but a Federal Register “final order” about an OTC ingredient’s effectiveness or enforcement is often regulatory/enforcement-driven rather than patent-driven. If your question is really about patent status or exclusivity affecting phenylephrine products, tell me the brand name(s) or product type and I can check what is covered. Otherwise, Federal Register/FDA dockets are usually the correct source for “final order” text.
Quick next step
Reply with any one of the following, and I’ll pinpoint the exact 2025–2026 Federal Register “final order” and summarize what it requires:
1) a quote or title fragment from the Federal Register entry
2) the docket number
3) the FDA document type (final rule vs final order vs final decision)
4) a specific company name tied to the notice
Sources
None yet (the exact Federal Register document wasn’t identified from your question).